PONENTE Study: Benralizumab Reduced or Eliminated Asthma Patient Oral Steroid Dependence

Retrieved on: 2022-01-27 10:05:05

Tags for this article:

Click the tags to see associated articles and topics

PONENTE Study: Benralizumab Reduced or Eliminated Asthma Patient Oral Steroid Dependence. View article details on hiswai:

Excerpt

The PONENTE trial was funded by AstraZeneca. Andrew Menzies-Gow reported attending advisory boards for AstraZeneca, GlaxoSmithKline, Novartis, ...

Article found on: www.physiciansweekly.com